Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.

Astrocytomas and oligodendrogliomas represent one third of histologically confirmed canine brain tumors. Our purpose was to describe the magnetic resonance (MR) imaging features of histologically confirmed canine intracranial astrocytomas and oligodendrogliomas and to examine for MR features that differentiate these tumor types. Thirty animals with confirmed astrocytoma (14) or oligodendroglioma (16) were studied. All oligodendrogliomas and 12 astrocytomas were located in the cerebrum or thalamus, with the remainder of astrocytomas in the cerebellum or caudal brainstem. Most (27/30) tumors were associated with both gray and white matter. The signal characteristics of both tumor types were hypointense on T1-weighted images (12 each) and hyperintense on T2-weighted images (11/14 astrocytomas, 12/16 oligodendrogliomas). For astrocytomas and oligodendrogliomas, respectively, common findings were contrast enhancement (10/13, 11/15), ring-like contrast enhancement (6/10, 9/11), cystic regions within the mass (7/14, 12/16), and hemorrhage (4/14, 6/16). Oligodendrogliomas were significantly more likely to contact the brain surface (meninges) than astrocytomas (14/16, 7/14, respectively, P=0.046). Contact with the lateral ventricle was the most common finding, occurring in 13/14 astrocytomas and 14/16 oligodendrogliomas. No MR features were identified that reliably distinguished between these two tumor types. Contrast enhancement was more common in high-grade tumors (III or IV) than low-grade tumors (II, P=0.008).

[1]  S. Schatzberg,et al.  Magnetic resonance imaging characteristics of necrotizing meningoencephalitis in Pug dogs. , 2009, Journal of veterinary internal medicine.

[2]  G. Stoica,et al.  Identification of Cancer Stem Cells in Dog Glioblastoma , 2009, Veterinary pathology.

[3]  L. Hudson,et al.  Clinical anatomy of the canine brain using magnetic resonance imaging. , 2008, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[4]  Chandrasekharan Kesavadas,et al.  Clinical applications of susceptibility weighted MR imaging of the brain – a pictorial review , 2008, Neuroradiology.

[5]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[6]  S. Horvath,et al.  Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2 , 2007, Clinical Cancer Research.

[7]  M. Herrtage,et al.  The relationship between clinical signs and brain herniation associated with rostrotentorial mass lesions in the dog. , 2006, Veterinary journal.

[8]  C. Rusbridge,et al.  Characteristics of magnetic resonance images of granulomatous meningoencephalomyelitis in 11 dogs , 2006, Veterinary Record.

[9]  Pieter Wesseling,et al.  Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database. , 2006, Journal of neurosurgery.

[10]  F. Shofer,et al.  Canine intracranial primary neoplasia: 173 cases (1986-2003). , 2006, Journal of veterinary internal medicine.

[11]  K. Matiasek,et al.  Magnetic resonance imaging and pathologic findings associated with necrotizing encephalitis in two Yorkshire terriers. , 2006, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[12]  Paul S Mischel,et al.  MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.

[13]  C. Lamb,et al.  Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats. , 2005, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[14]  Mitchel S Berger,et al.  Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.

[15]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.

[16]  M. Maschke,et al.  Neuroimaging of infections , 2005, NeuroRX.

[17]  A. Bollen,et al.  Glioblastoma Multiforme: Clinical Findings, Magnetic Resonance Imaging, and Pathology in Five Dogs , 2003, Veterinary pathology.

[18]  Scott W. Atlas,et al.  Magnetic Resonance Imaging of the Brain and Spine , 1991 .

[19]  Sajja B Rao,et al.  Differentiation of Calcification from Chronic Hemorrhage with Corrected Gradient Echo Phase Imaging , 2001, Journal of computer assisted tomography.

[20]  A. Kalnin,et al.  Correlation between the degree of contrast enhancement and the volume of peritumoral edema in meningiomas and malignant gliomas , 1999, Neuroradiology.

[21]  C A Beltrami,et al.  Analysis of cystic intracranial lesions performed with fluid-attenuated inversion recovery MR imaging. , 1999, AJNR. American journal of neuroradiology.

[22]  L. Bozzao,et al.  Radiological assessment of necrosis in glioblastoma: variability and prognostic value , 1998, Neuroradiology.

[23]  M. Nakaichi,et al.  Magnetic resonance imaging of the lateral ventricles in beagle-type dogs. , 1997, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[24]  P. Gavin,et al.  Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging. , 1997, Journal of veterinary internal medicine.

[25]  A. Holodny,et al.  MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema , 1997, Neuroradiology.

[26]  J. Kornegay,et al.  Cystic meningiomas in 2 dogs. , 1996, Journal of veterinary internal medicine.

[27]  B. Scheithauer,et al.  Oligodendrogliomas: the Mayo Clinic experience. , 1992, Journal of neurosurgery.

[28]  R. Dodge,et al.  Analysis of survival in a retrospective study of 86 dogs with brain tumors. , 1991, Journal of veterinary internal medicine.

[29]  S. Kraft,et al.  Diffuse Cerebral and Leptomeningeal Astrocytoma in Dogs: MR Features , 1990, Journal of computer assisted tomography.

[30]  R L Ehman,et al.  Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. , 1988, Radiology.

[31]  S. Atlas,et al.  Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. , 1987, Radiology.

[32]  B A Kall,et al.  Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.

[33]  T. H. Newton,et al.  Cystic intracranial lesions: magnetic resonance imaging. , 1985, Radiology.

[34]  W. Priester,et al.  Occurrence of nervous‐tissue tumors in cattle, horses, cats and dogs , 1975, International journal of cancer.

[35]  M. Pumarola,et al.  Magnetic resonance imaging findings in 40 dogs with histologically confirmed intracranial tumours. , 2011, Veterinary journal.

[36]  D. Louis WHO classification of tumours of the central nervous system , 2007 .

[37]  B. Scheithauer,et al.  Diffuse “fibrillary” astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade , 2004, Neuroradiology.

[38]  J K Smith,et al.  Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.

[39]  R. W. Kramer,et al.  MAGNETIC RESONANCE IMAGING FEATURES OF PRIMARY BRAIN TUMORS IN DOGS , 1996 .

[40]  J. M. Owens,et al.  INTRACRANIAL RING ENHANCING LESIONS IN DOGS: A CORRELATIVE CT SCANNING AND NEUROPATHOLOGIC STUDY , 1995 .

[41]  R Fankhauser,et al.  Tumours of the nervous system. , 1974, Bulletin of the World Health Organization.